The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir tablets in strengths of 600 mg and 800 mg, the Hyderabad-based drug maker said in a regulatory filing.
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir tablets in strengths of 600 mg and 800 mg, the Hyderabad-based drug maker said in a regulatory filing. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir tablets in strengths of 600 mg and 800 mg, the Hyderabad-based drug maker said in a regulatory filing. Moneycontrol Latest News Read More
हिन्दी 
English